Erythrocytes, Platelets, and Plasma Proteins

This term collectively refers to three distinct blood constituents: **erythrocytes** (red blood cells), responsible for oxygen and carbon dioxide transport; **platelets** (thrombocytes), which are cell fragments essential for blood clot formation and vascular integrity; and **plasma proteins**, a heterogeneous group of proteins in blood plasma including albumin (for oncotic pressure and solute transport), globulins (including immunoglobulins), and coagulation factors such as fibrinogen. These components have fundamental but non-overlapping roles in physiology, and abnormalities contribute to a wide range of hematological and systemic diseases. None are considered a single molecular target suitable for conventional receptor/enzyme/transporter drug targeting, though each can be manipulated or substituted therapeutically in disease contexts[1][2][5][6][7].

Other names

Red blood cells, thrombocytes, and plasma proteinsRBCs, platelets, and plasma proteins

Erythropoiesis stimulation (by erythropoietin) Thrombopoiesis stimulation (by thrombopoietin or receptor agonists) Replacement of deficient components (transfusions/recombinant proteins) Inhibition of platelet activation/aggregation (antiplatelet drugs) Inhibition of coagulation (anticoagulants, targeting plasma protein cascade)